Active Development

Reset

Delivery Type

Reset

Duration Type

Reset

Developer

Reset

User

Reset

Hormonal

Reset

Development Stage

Reset

Potential MPT

Reset

API

Reset
Displaying 61 - 70 of 70
Active Status: Unknown
User: Female
Mode: No
Developer: Rutgers University
Project Stage: Lead Optimization
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Other
Project Stage: Lead Optimization
Target
Active Status: Unknown
User: Male
Mode: No
Developer: Baylor College of Medicine, NICHD
Role in reproduction: Spermatogenesis
Project Stage: Target Validation
Alternative Name: RISUG in the Fallopian Tube
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Fallopian Tube
Developer: Indian Institute of Technology, Kharagpur
Project Stage: Prototype Development
Alternative Name: Tripterygium wilfordii derivatives, including triptolide
Active Status: No
User: Male
Mode: No
Developer: WHO, University of California at Los Angeles
Project Stage: Lead Optimization
Active Status: Yes
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: FHI 360, GE Healthcare
Project Stage: Prototype Development
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Vaginal, Other
Developer: University of Texas Health Science Center at San Antonio
Project Stage: Lead Optimization
Alternative Name: WEE1 HOMOLOG 2; WEE1B; WEE2 Kinase
Target
Active Status: Yes
User: Female
Mode: No
Developer: Oregon Health & Science University, University of Minnesota
Role in reproduction: Oocyte Maturation
Project Stage: Lead Optimization
Alternative Name: Miglustat; N-butyldeoxynojirimycin (NB-DNJ)
Active Status: No
User: Male
Mode: No
Delivery Type: Oral
Developer: University of Washington, Oxford GlycoSciences
Project Stage: Lead Optimization
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Vaginal Gel
Developer: University of Nairobi
Project Stage: Lead Optimization

Pages

CSV